Bolt Biotherapeutics Inc
Research Bolt Biotherapeutics Inc (BOLT) on Bullrun: market cap USD 7.40M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBOLT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 7.40M
- Financial periodQ1 2026
- RevenueUSD 26.00K
- Net income-USD 7.24M
- Free cash flow-USD 34.58M
Valuation Snapshot
latest market cap is USD 7.40M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 7.70M | -USD 33.38M | -USD 39.92M | n/a | -17.85 | USD 11.70M | USD 22.96M | USD 26.51M |
| FY2024 | USD 7.69M | -USD 63.12M | -USD 61.33M | n/a | -33.06 | USD 7.21M | USD 25.21M | USD 57.20M |
| FY2023 | USD 7.88M | -USD 69.20M | -USD 69.73M | n/a | -1.83 | USD 10.81M | USD 20.22M | USD 112.74M |
| FY2022 | USD 5.73M | -USD 88.10M | -USD 78.46M | n/a | -2.36 | USD 9.24M | USD 22.89M | USD 171.51M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 7.40M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 10.50M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 20.51M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 42.52M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 48.96M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 183.26M | n/a | n/a | n/a |
About Bolt Biotherapeutics Inc
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bolt Biotherapeutics Inc's market cap?
Bolt Biotherapeutics Inc's market capitalization is USD 7.40M.
What does Bolt Biotherapeutics Inc do?
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer.